PT Maskapai Reasuransi Indonesia Tbk (MREI) Fair Value & Analysis
Financial Services · ID · Market cap 476B IDR
Fair value as of: Jul 16, 2026
From 6 valuation models · updated 25 days ago
Share price −6.6% over the past month.
A solid business, screening 39% undervalued on our models.
What matters now
- The price is below even our cautious bear case (956.78 IDR). The market is more pessimistic than our downside scenario.
- Solid quality (57/100) at a price below fair value, the discount is the argument here, not the business quality.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.
How to read this chart
60‑month range 632.83 IDR – 5,475 IDR · fair‑value band 956.78 IDR – 1,595 IDR · the 920.00 IDR price screens below the 1,276 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 16, 2026.
Analysis
PT Maskapai Reasuransi Indonesia Tbk (MREI) currently trades at 920.00 IDR, while our model-based Fair Value estimate is 1,276 IDR, implying the stock looks roughly 38.7% undervalued today. The Quality Score stands at 57/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, PT Maskapai Reasuransi Indonesia Tbk generated revenue of 2.3T IDR at a net margin of 3.9%. Revenue grew 15.1% year over year. It earns a return on equity of 5.8%. The balance sheet holds a net cash position of 530B IDR. Fundamentals as of Jul 16, 2026
Our scenario range runs from 956.78 IDR (bear case) to 1,595 IDR (bull case); at 920.00 IDR, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 42% below its 52-week high and 33% above its 52-week low, currently below its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 96% fair-value upside, at 39%, MREI screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 6 models by family
Widest divergence: Economic Profit (2,047 IDR) versus Dividend Discount (231.39 IDR). Highest evidence: Residual Income (76).
Notify me when MREI reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 58 · Market factors (momentum, volatility) 36
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PT Maskapai Reasuransi Indonesia Tbk engages in the reinsurance business in Indonesia. The company offers general reinsurance products, such as property, motor vehicle, marine hull and cargo, aviation, health, liability, personal accident, suretyship, and engineering reinsurance, as well as energy, and oil and gas reinsurance.
Full company description
PT Maskapai Reasuransi Indonesia Tbk engages in the reinsurance business in Indonesia. The company offers general reinsurance products, such as property, motor vehicle, marine hull and cargo, aviation, health, liability, personal accident, suretyship, and engineering reinsurance, as well as energy, and oil and gas reinsurance. It provides life reinsurance, including term life, personal accident, credit life, critical illness, health, and catastrophe reinsurance products, as well as Sharia life and general reinsurance products. The company was founded in 1953 and is based in Jakarta Selatan, Indonesia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
PT Maskapai Reasuransi Indonesia Tbk reported revenue of 2.3T IDR in FY2024 versus 2.0T IDR in FY2020, a compound +3.5%/yr. Reported net income was 50.8B IDR in FY2024, compounding −16.6%/yr from FY2020.
of which total revenue +12.3 pp · buybacks/dilution −2.9 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch MREI: get an alert when its fair value changes →
Peer Group
Insurance - Reinsurance · 28 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Insurance - Reinsurance median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Insurance - Reinsurance stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| 1MUV2 1MUV2 | €522.60 | €669.36 | +28% |
| Swiss Re AG SREN | CHF 132.60 | CHF 218.88 | +65% |
| Hannover Rück SE HNR1 | €255.00 | €284.58 | +12% |
| Reinsurance Group RGA | $241.79 | $234.55 | -3% |
| Everest Group EG | $364.13 | $522.67 | +44% |
| RenaissanceRe Holdings RNR | $314.99 | $629.98 | +100% |
| SCOR SE SDRC | €33.04 | €66.08 | +100% |
| General Insurance Corporation GICRE | ₹364.85 | ₹715.98 | +96% |
| China Reinsurance (Group) Corporation 1508 | HK$1.37 | HK$2.74 | +100% |
| Hamilton Insurance Group HG | $34.60 | $69.20 | +100% |
Compare PT Maskapai Reasuransi Indonesia Tbk with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is PT Maskapai Reasuransi Indonesia Tbk (MREI) overvalued or undervalued?
What is the fair value of MREI?
What is the quality score of MREI?
What is the revenue of PT Maskapai Reasuransi Indonesia Tbk (MREI)?
What is the net profit margin of MREI?
Does PT Maskapai Reasuransi Indonesia Tbk pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PT Maskapai Reasuransi Indonesia Tbk and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.